Advertisement

Topics

Kirin Brewery Co.,LTD Company Profile

08:29 EST 13th December 2018 | BioPortfolio

Nil

Location

2-10-1 Shinkawa
Tokyo
Chuo-ku
104-8288
Japan

Contact

Phone: 03(5540)3411
Fax: 03(5540)3547


News Articles [88 Associated News Articles listed on BioPortfolio]

Kyowa Kirin gibt positive Stellungnahme des CHMP zu Mogamulizumab zur Behandlung von Mycosis fungoides und Sézary-Syndrom bekannt

Tokio (ots/PRNewswire) - Mogamulizumab wäre nach Zulassung der erste biologische Wirkstoff gegen CCR4 für Patienten in Europa. Kyowa Hakko Kirin Co., Ltd., (Kyowa Kirin), hat heute bekanntgegeben, ....

Kyowa Hakko Kirin Announces FDA Notification of PDUFA Action Date Extension for Mogamulizumab

Tokyo, Japan, May 30, 2018 –Kyowa Hakko Kirin Co., Ltd. (Tokyo: 4151 President and COO: Masashi Miyamoto, “Kyowa Hakko Kirin”) announced today that it has been notified that the U.S. Food and Dr...

EU approves Kyowa Kirin's drug for rare lymphoma

The European Commission has approved Poteligeo (mogamulizumab), a treatment for rare types of non-Hodgkin’s lymphoma. The drug is manufactured by Japanese firm Kyowa Hakko Kirin (Kyowa Kirin), and ...

Kyowa Kirin Announces POTELIGEO® Receives Marketing Authorisation in Europe for the Treatment of Mycosis Fungoides and Sézary Syndrome

Tokyo (ots/PRNewswire) - POTELIGEO will be the first biologic agent targeting CCR4 to be available for patients in Europe. Kyowa Hakko Kirin Co., Ltd., (Kyowa Kirin) announces today that it has rec...

FDA Approves Kyowa Kirin’s Poteligeo for Treatment of Two Rare Types of Non-Hodgkin Lymphoma

TOKYO, Aug. 8, 2018 /PRNewswire/ — Kyowa Hakko Kirin Co., Ltd., (Kyowa Kirin) announces today that the U.S. Food and Drug Administration (FDA) has granted approval for Poteligeo® (mogamulizumab...

Ultragenyx and Kyowa Kirin Announce Health Canada Approval of Crysvita

Ultragenyx Pharmaceutical (NASDAQ:RARE), a biopharmaceutical company focused on the development of novel products for serious rare and ultra-rare genetic diseases, Kyowa Hakko Kirin and Kyowa Kirin In...

FDA approves Kyowa Kirin’s Poteligeo to treat two lymphoma types

The US Food and Drug Administration (FDA) has granted approval to biotechnology company Kyowa Kirin’s Poteligeo (mogamulizumab-kpkc) injection to treat...Read More... The post FDA approves Kyowa...

Kyowa Hakko Kirin Co., Ltd. Strategy, SWOT and Corporate Finance Report [Report Updated: 20062018] Prices from USD $175

Kyowa Hakko Kirin Co., Ltd. Strategy, SWOT and Corporate Finance ReportSummaryKyowa Hakko Kirin Co., Ltd. Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and i...

Drugs and Medications [0 Results]

None

PubMed Articles [11 Associated PubMed Articles listed on BioPortfolio]

Microwave-assisted one-pot conversion of agro-industrial wastes into levulinic acid: An alternate approach.

Brewery liquid waste (BLW), brewery spent grain (BSG), apple pomace solid wastes (APS), apple pomace ultrafiltration sludge (APUS) and starch industry waste (SIW) were evaluated as alternative feedsto...

Comparative Genomics of Lactobacillus brevis Reveals a Significant Plasmidome Overlap of Brewery and Insect Isolates.

Lactobacillus (L.) brevis represents a versatile, ubiquitistic species of lactic acid bacteria, occurring in various foods, as well as plants and intestinal tracts. The ability to deal with considerab...

The Student t-test is a beer test.

The Student-t-test, one of the most used statistical tests in medicine, was developed by a beer brewer. From around 1900, the Irish Guinness brewery started recruiting scientists for the position of b...

Production of xylanolytic enzymes by Moesziomyces spp. using xylose, xylan and brewery's spent grain as substrates.

Xylanases play a crucial role in the hydrolysis of xylan-rich hemicelluloses and have wide industrial applications in the fuel, food, feed and pulp and paper industries. The production of these enzyme...

Competitive inter-species interactions underlie the increased antimicrobial tolerance in multispecies brewery biofilms.

Genetic diversity often enhances the tolerance of microbial communities against antimicrobial treatment. However the sociobiology underlying this antimicrobial tolerance remains largely unexplored. He...

Clinical Trials [0 Results]

None

Companies [17 Associated Companies listed on BioPortfolio]

Kirin Brewery Co.,LTD

Nil

Kirin Brewery Company Limited

Drug Discovery

Hematech, Inc.

Hematech, LLC was founded in 1998 and has its corporate headquarters in Sioux Falls, SD. In 1999, Hematech and the Pharmaceutical Division of the Kirin Brewery Company began a research collaboration t...

Kyowa Hakko Kirin Co. Ltd.

Kyowa Hakko Kirin Co., Ltd.

More Information about "Kirin Brewery Co.,LTD" on BioPortfolio

We have published hundreds of Kirin Brewery Co.,LTD news stories on BioPortfolio along with dozens of Kirin Brewery Co.,LTD Clinical Trials and PubMed Articles about Kirin Brewery Co.,LTD for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Kirin Brewery Co.,LTD Companies in our database. You can also find out about relevant Kirin Brewery Co.,LTD Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record